Mesoblast Update – CORRECTION

Mesoblast
Reddit

Last week I wrote a short update on the company Mesoblast [ASX:MSB]. In that update I noted that the downtrend in the stock had began after ‘after the company received disappointing results from a trial.’

That was a complete mistake on my part, and needs to be corrected. I confused two different companies and wrongly attributed the disappointing trial result to Mesoblast.

The article was removed from our website as soon as I became aware of the error.

I apologise for the mistake.

Callum Newman
Editor, The Daily Reckoning

Join The Daily Reckoning on Google+

Callum Newman

Callum Newman

Callum Newman is the editor of The Daily Reckoning and Associate Editor of Cycles, Trends and Forecasts. He also hosts The Daily Reckoning Podcast. Originally graduating with a degree in Communications, Callum decided financial markets were far more fascinating than anything Marshall McLuhan (the ‘medium is the message’) ever came up with. Today Callum spends his day reading and researching why currencies, commodities and stocks move like they do. So far he’s discovered it’s often in a way you least expect. To have Callum’s thoughts and insights on the current state of the currency, commodities and stock markets delivered straight to your inbox, take out a free subscription to The Daily Reckoning here.
Reddit

Leave a Reply

Be the First to Comment!

Notify of
avatar
wpDiscuz
Letters will be edited for clarity, punctuation, spelling and length. Abusive or off-topic comments will not be posted. We will not post all comments.
If you would prefer to email the editor, you can do so by sending an email to letters@dailyreckoning.com.au